Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Direct Oral Anticoagulants Versus Warfarin for Preventing Stroke and Systemic Embolic Events Among Atrial Fibrillation Patients With Chronic Kidney Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/images/closex.png. Accessed 03 May 2024.
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/images/closex.png. Accessed May 3, 2024.
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/images/closex.png
Direct Oral Anticoagulants Versus Warfarin for Preventing Stroke and Systemic Embolic Events Among Atrial Fibrillation Patients With Chronic Kidney Disease [Internet]. In: Cochrane Abstracts. [cited 2024 May 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/images/closex.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
ID - 433620
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433620/all/images/closex.png
DB - Evidence Central
DP - Unbound Medicine
ER -